J L Winkelhake - Concepedia

Author

J L Winkelhake

Also Known As

J L Winkelhake, J Winkelhake, J. L. Winkelhake, J. Winkelhake, J.L. WINKELHAKE, J.L. Winkelhake, JL Winkelhake, Raymond A. Dwek

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Medical College of Wisconsin CEP America Salk Institute for Biological Studies

About

J L Winkelhake is an author at Medical College of Wisconsin specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	732
2	Engineering	2	2	119
3	Health Sciences	1	1	96
4	Natural Sciences	1	1	42
5	Public Health	1	1	33

J L Winkelhake

Publications

976

Citations

H-Index

Page 1

	Year	Citations
A sensitive ELISPOT assay to detect low-frequency human T lymphocytes M McCutcheon, Nancy Wehner, Allen Wensky, Journal of Immunological Methods Autoimmune DiseaseAllergyLaboratory ImmunologyMedicineImmunology	1997	162
The role of oxidant injury in tumor cell sensitivity to recombinant human tumor necrosis factor <i>in vivo</i>. Implications for mechanisms of action. Robert J. Zimmerman, B J Marafino, Alex Chan, The Journal of Immunology	1989	133
Aglycosylantibody. Effects of exoglycosidase treatments on autochthonous antibody survival time in the circulation. J L Winkelhake, Garth L. Nicolson Journal of Biological Chemistry ImmunohematologyImmunocytochemical TechniqueRabbit Anti-hapten AntibodiesImmunologyGlycobiology	1976	96
Antigenic Specificity of Bactericidal Antibodies in Antisera to Neisseria meningitidis Dennis L. Kasper, J L Winkelhake, B. L. Brandt, The Journal of Infectious Diseases VaccinationPolysaccharide AntigenAntibody BindingMedical MicrobiologyAntimicrobial Susceptibility	1973	75
Effect of Culture Conditions on IgM Antibody Structure, Pharmacokinetics and Activity B. Maiorella, J L Winkelhake, Bryan D. Moyer, Bio/Technology Culture ConditionsIgm Antibody StructureMedicineImmunologyAutoimmunity	1993	69
A phase I trial of solubilized DR2:MBP <sup>84-102</sup> (AG284) in multiple sclerosis Donald E. Goodkin, Megan Shulman, J L Winkelhake, Neurology	2000	68
Gd-DTPA contrast enhancement and tissue differentiation in MR imaging of experimental breast carcinoma. D. Revel, R C Brasch, Hannu Paajanen, Radiology Tissue DifferentiationEngineeringOncologic ImagingPet-mriMagnetic Resonance	1986	67
Schedule dependency of the antitumor activity and toxicity of polyethylene glycol-modified interleukin 2 in murine tumor models. Robert J. Zimmerman, Sharon L. Aukerman, Nandini V. Katre, PubMed Peg-il-2 TreatmentAntitumor ActivityChemoprevention StrategyImmunologyMetronomic Chemotherapy	1989	54
Contrast-enhanced magnetic resonance imaging of tumor-bearing mice treated with human recombinant tumor necrosis factor alpha. Klaus P. Aicher, JEAN W. DUPON, David L. White, PubMed EngineeringImaging AgentPathologyTumor BiologyMagnetic Resonance Imaging	1990	52
Effects of pH treatments and deglycosylation of rabbit immunoglobulin G on the binding of C1q. J L Winkelhake, Thomas J. Kunicki, Barbara M. Elcombe, Journal of Biological Chemistry Bioorganic ChemistryPolypeptide BackboneLaboratory ImmunologyImmunologyGlycobiology	1980	42

Page 1